Literature DB >> 22878563

Hypoxic preconditioning up-regulates DJ-1 protein expression in rat heart-derived H9c2 cells through the activation of extracellular-regulated kinase 1/2 pathway.

Hai-Shan Lu1, He-Ping Chen, Song Wang, Hai-Hong Yu, Xiao-Shan Huang, Qi-Ren Huang, Ming He.   

Abstract

Myocardial preconditioning is a powerful phenomenon that can attenuate ischemia/reperfusion-induced oxidant stress and elicit delayed cardioprotection. Its mechanisms involve activation of intracellular signaling pathways and up-regulation of the protective antioxidant proteins. DJ-1 protein, as a multifunctional intracellular protein, plays an important role in attenuating oxidant stress and promoting cell survival. In the present study, we investigated whether DJ-1 is up-regulated during the late phase of hypoxic preconditioning (HP) and the up-regulation of DJ-1 is mediated by extracellular-regulated kinase 1/2 (ERK1/2) signaling pathway. Rat heart-derived H9c2 cells were exposed to HP. Twenty-four hours later cells were subjected to hypoxia/reoxygenation (H/R) and then cell viability, lactate dehydrogenase (LDH), intracellular reactive oxygen species (ROS), ERK1/2 phosphorylation, and DJ-1 protein were measured appropriately. The results showed that HP efficiently attenuated H/R-induced viability loss and LDH leakage. In addition, HP promoted ERK1/2 activation, up-regulated DJ-1 protein expression, inhibited H/R induced the elevation of ROS. However, when ERK1/2 phosphorylation was specifically inhibited by U0126, the increase in DJ-1 expression occurring during HP was almost completely abolished and, as a result, the delayed cardioprotection induced by HP was abolished, and the inhibitory effect of HP on H/R-induced oxidant stress was also reversed. Furthermore, knocking down DJ-1 by siRNA attenuated the delayed cardioprotection induced by HP. Our data indicate that HP can up-regulate DJ-1 protein expression through the ERK1/2-dependent signaling pathway. Importantly, DJ-1 might be involved in the delayed cardioprotective effect of HP against H/R injury.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22878563     DOI: 10.1007/s11010-012-1414-8

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  26 in total

1.  Ischemic preconditioning enhances scavenging activity of reactive oxygen species and diminishes transmural difference of infarct size.

Authors:  Masahiko Morihira; Naoyuki Hasebe; Erdenechimeg Baljinnyam; Kazuhiro Sumitomo; Tomoyuki Matsusaka; Kazuma Izawa; Takayuki Fujino; Jun Fukuzawa; Kenjiro Kikuchi
Journal:  Am J Physiol Heart Circ Physiol       Date:  2005-07-22       Impact factor: 4.733

2.  PKC-dependent activation of p44/p42 MAPKs during myocardial ischemia-reperfusion in conscious rabbits.

Authors:  P Ping; J Zhang; X Cao; R C Li; D Kong; X L Tang; Y Qiu; S Manchikalapudi; J A Auchampach; R G Black; R Bolli
Journal:  Am J Physiol       Date:  1999-05

3.  Increased protein synthesis is necessary for the development of late preconditioning against myocardial stunning.

Authors:  A Rizvi; X L Tang; Y Qiu; Y T Xuan; H Takano; A K Jadoon; R Bolli
Journal:  Am J Physiol       Date:  1999-09

4.  DJ-1, a novel oncogene which transforms mouse NIH3T3 cells in cooperation with ras.

Authors:  D Nagakubo; T Taira; H Kitaura; M Ikeda; K Tamai; S M Iguchi-Ariga; H Ariga
Journal:  Biochem Biophys Res Commun       Date:  1997-02-13       Impact factor: 3.575

Review 5.  The importance of manganese superoxide dismutase in delayed preconditioning: involvement of reactive oxygen species and cytokines.

Authors:  Shiro Hoshida; Nobushige Yamashita; Kinya Otsu; Masatsugu Hori
Journal:  Cardiovasc Res       Date:  2002-08-15       Impact factor: 10.787

6.  [Different roles of ERK(1/2) and p38 MAPK(alpha/beta) in cellular signaling during cardiomyocyte anoxia preconditioning].

Authors:  Yi-Feng Huang; Kai-Zheng Gong; Zhen-Gang Zhang
Journal:  Sheng Li Xue Bao       Date:  2003-08-25

7.  Novel functional role of heat shock protein 90 in ATP-sensitive K+ channel-mediated hypoxic preconditioning.

Authors:  Jun-Dong Jiao; Vivek Garg; Baofeng Yang; Keli Hu
Journal:  Cardiovasc Res       Date:  2007-10-04       Impact factor: 10.787

8.  Synergistic activation of the human MnSOD promoter by DJ-1 and PGC-1alpha: regulation by SUMOylation and oxidation.

Authors:  Nan Zhong; Jin Xu
Journal:  Hum Mol Genet       Date:  2008-08-08       Impact factor: 6.150

9.  Oxidative insults induce DJ-1 upregulation and redistribution: implications for neuroprotection.

Authors:  Nirit Lev; Debby Ickowicz; Eldad Melamed; Daniel Offen
Journal:  Neurotoxicology       Date:  2008-03-10       Impact factor: 4.294

10.  DJ-1 has a role in antioxidative stress to prevent cell death.

Authors:  Takahiro Taira; Yoshiro Saito; Takeshi Niki; Sanae M M Iguchi-Ariga; Kazuhiko Takahashi; Hiroyoshi Ariga
Journal:  EMBO Rep       Date:  2004-01-23       Impact factor: 8.807

View more
  10 in total

1.  Conditioning Against the Pathology of Parkinson's disease.

Authors:  Rehana K Leak
Journal:  Cond Med       Date:  2018-04-28

2.  GBA1 deficiency negatively affects physiological α-synuclein tetramers and related multimers.

Authors:  Sangjune Kim; Seung Pil Yun; Saebom Lee; George Essien Umanah; Veera Venkata Ratnam Bandaru; Xiling Yin; Peter Rhee; Senthilkumar S Karuppagounder; Seung-Hwan Kwon; Hojae Lee; Xiaobo Mao; Donghoon Kim; Akhilesh Pandey; Gabsang Lee; Valina L Dawson; Ted M Dawson; Han Seok Ko
Journal:  Proc Natl Acad Sci U S A       Date:  2018-01-08       Impact factor: 12.779

3.  Hypoxia induces connexin 43 dysregulation by modulating matrix metalloproteinases via MAPK signaling.

Authors:  Xianghong Wu; Wen Huang; Gang Luo; Laval Andy Alain
Journal:  Mol Cell Biochem       Date:  2013-09-04       Impact factor: 3.396

Review 4.  Parkinson's disease proteins: Novel mitochondrial targets for cardioprotection.

Authors:  Uma A Mukherjee; Sang-Bing Ong; Sang-Ging Ong; Derek J Hausenloy
Journal:  Pharmacol Ther       Date:  2015-10-19       Impact factor: 12.310

5.  Molecular Mechanism Underlying Hypoxic Preconditioning-Promoted Mitochondrial Translocation of DJ-1 in Hypoxia/Reoxygenation H9c2 Cells.

Authors:  Yi-Zhang Deng; Lin Xiao; Le Zhao; Le-Jia Qiu; Zhao-Xia Ma; Xing-Wang Xu; Hao-Yue Liu; Ting-Ting Zhou; Xue-Ying Wang; Lei Tang; He-Ping Chen
Journal:  Molecules       Date:  2019-12-24       Impact factor: 4.411

6.  DJ-1 protects against cell death following acute cardiac ischemia-reperfusion injury.

Authors:  R K Dongworth; U A Mukherjee; A R Hall; R Astin; S-B Ong; Z Yao; A Dyson; G Szabadkai; S M Davidson; D M Yellon; D J Hausenloy
Journal:  Cell Death Dis       Date:  2014-02-27       Impact factor: 8.469

7.  Hyperglycemia-induced inhibition of DJ-1 expression compromised the effectiveness of ischemic postconditioning cardioprotection in rats.

Authors:  Min Liu; Bin Zhou; Zhong-Yuan Xia; Bo Zhao; Shao-Qing Lei; Qing-Jun Yang; Rui Xue; Yan Leng; Jin-Jin Xu; Zhengyuan Xia
Journal:  Oxid Med Cell Longev       Date:  2013-11-04       Impact factor: 6.543

8.  Hypoxic preconditioning stimulates angiogenesis in ischemic penumbra after acute cerebral infarction.

Authors:  Sijie Li; Yanbo Zhang; Guo Shao; Mingfeng Yang; Jingzhong Niu; Guowei Lv; Xunming Ji
Journal:  Neural Regen Res       Date:  2013-11-05       Impact factor: 5.135

Review 9.  Cytoprotective Mechanisms of DJ-1: Implications in Cardiac Pathophysiology.

Authors:  James N Tsoporis; Ioannis-Alexandros Drosatos; Sahil Gupta; Hajera Amatullah; Shehla Izhar; Claudia C Dos Santos; Vasileos Salpeas; Angelos G Rigopoulos; Ioannis K Toumpoulis; Andreas S Triantafyllis; Eleftharios Sakadakis; Nikolaos Kavantzas; John C Marshall; Ioannis K Rizos; Thomas G Parker
Journal:  Molecules       Date:  2021-06-22       Impact factor: 4.411

Review 10.  Cardiac Changes in Parkinson's Disease: Lessons from Clinical and Experimental Evidence.

Authors:  Lorena Cuenca-Bermejo; Pilar Almela; Javier Navarro-Zaragoza; Emiliano Fernández Villalba; Ana-María González-Cuello; María-Luisa Laorden; María-Trinidad Herrero
Journal:  Int J Mol Sci       Date:  2021-12-16       Impact factor: 5.923

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.